Aldosterone as a determinant of cardiovascular and renal dysfunction.
Epstein
M
M
Department of Medicine, University of Miami School of Medicine, Miami, FL 33125, USA. murraye@gate.net
D000450:Aldosterone / Q000502:physiology*; D000804:Angiotensin II / Q000378:metabolism; D000818:Animals; D002318:Cardiovascular Diseases / Q000188:drug therapy / Q000378:metabolism*; D004730:Endothelium, Vascular / Q000378:metabolism; D005355:Fibrosis; D006801:Humans; D007674:Kidney Diseases / Q000188:drug therapy / Q000378:metabolism*; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D009569:Nitric Oxide / Q000378:metabolism; D011188:Potassium / Q000378:metabolism; D016032:Randomized Controlled Trials as Topic; D012964:Sodium / Q000378:metabolism; D013148:Spironolactone / Q000627:therapeutic use
D000451:Mineralocorticoid Receptor Antagonists; D000804:Angiotensin II; D013148:Spironolactone; D009569:Nitric Oxide; D000450:Aldosterone; D012964:Sodium; D011188:Potassium